Since our studies indicate that m6A and reader proteins YTHDF1 and YTHDC1 regulate the viral transcriptome (an essential phenomenon for ATLL development), subsequent chemotherapy-alternatives may be aimed at targeting these reader proteins or the m6A writer protein METTL3 (via STM2457). The gene discussed is YTHDF1; the disease is adult T-cell leukemia/lymphoma.